Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OMB omega-3 request

This article was originally published in The Tan Sheet

Executive Summary

OMB urges HHS, USDA to modify the Dietary Guidelines and Food Guide Pyramid to include new information stating omega-3 fatty acids may reduce the risk of coronary heart disease, while trans fatty acids may increase risk of CHD, according to May 28 1"prompt" letter. OMB bases its request on "epidemiologic and clinical studies finding that an increase in consumption of omega-3 fatty acids results in reduced deaths due to CHD." OMB also points to American Heart Association's recent revision of its dietary guidelines to recommend eating fish, which is high in omega-3 fatty acids, twice weekly (2"The Tan Sheet" Dec. 2, 2002, In Brief). "Prompt" letter, which is used by Bush Administration to highlight issues considered worthy of priority status, requests meeting "in the next few weeks to discuss this issue"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel